Blue chip stocks can be an ideal addition to your portfolio if you are risk-averse. These companies enjoy a favorable reputation and historic stability in the markets. Based on the latest activity, these 4 blue chip stocks have been gaining fast.
A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood’s Ark Funds. A look at the stocks both well-known financial figures like. Continue reading ➔
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don’t take action today, your wealth could decline by 40%… (Yes, even your cash savings.) Here’s his crystal-clear game plan for what to do.
Personal finance expert Dave Ramsey has long dismissed crypto, gold and single-stock investing, calling them risky distractions — but new research shows that his disciplined mutual fund approach may have cost him market-beating returns. Continue reading ➔
WASHINGTON (AP) — Naturepedic, a mattress and furniture company based outside Cleveland, has been planning to introduce an upscale upholstered headboard late this year or early in 2026. Continue reading ➔
The President recently announced his plans for a crypto strategic reserve. This would be a massive stockpile of crypto the U.S. government would hold. And the first crypto he mentioned was a $3 crypto that most Americans probably have never heard of. See Bryan’s breakdown of the situation right here.
The White House clarified that the $100,000 H-1B visa fee is a one-time charge, not an annual fee, amid confusion among major tech companies. Continue reading ➔
FDA approves Merck’s Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September. Continue reading ➔
Elon Musk: “Tesla will become a $25 trillion company.” That would make Tesla 8x bigger than Apple today. How is that possible? He admits it’s all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world. See Tesla’s REAL master plan here
U.S. Attorney Erik Siebert resigned after refusing Trump administration pressure to charge New York AG Letitia James without evidence, a move critics call political retribution. Continue reading ➔
Betting markets are buzzing with speculation about Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk potentially joining the Trump Administration by the end of 2025. Continue reading ➔
When the U.S. Treasury Secretary’s largest personal holding is gold… that’s known as “a clue.” Warren Buffett sees this. I believe he’s preparing to buy the one gold miner large enough to protect his cash. And here’s the kicker… Confirmation of my prediction could come by November 15. Get the name and ticker of Buffett’s next move into gold.
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades. Continue reading ➔
President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current medical recommendations. Continue reading ➔
Tennessee will surge federal agents, deputized Guard, and $100M in support to Memphis, launching a multi-agency task force to combat violent crime. Continue reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.